MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,382,620 | -17.7% | 792,872 | +11.0% | 0.15% | -10.6% |
Q2 2023 | $7,754,159 | +5273.4% | 714,011 | +3314.0% | 0.17% | +5566.7% |
Q1 2023 | $144,307 | +51.5% | 20,914 | -12.6% | 0.00% | +50.0% |
Q4 2022 | $95,229 | -69.4% | 23,927 | -28.1% | 0.00% | -71.4% |
Q1 2022 | $311,000 | – | 33,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |